RxDoctor Payments Data

Faramarz Alizadeh Shabdiz, MD

Otolaryngology · Orange, CANPI 1790955052

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Cook Incorporated accounts for 89.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $13,159 and has fallen 99.5% since, to $67 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,150in general payments, 2019–2025

Across 85 payments — averaging $178.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$14K
  • Optinose US, Inc.$791
  • Medtronic$185
  • Stryker$106
  • Inspire Medical Systems, Inc.$91
  • GSK$88
  • plus $288 from 7 others

What the payments were for

  • Consulting fees$8,66057%
  • Speaking & faculty fees$5,00033%
  • Food & beverage$1,49010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,150 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024
$228,870
Medicare patients
389
Services billed
1,365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth29$2,646
Azelastine Hcl116$2,524
Fluticasone Propionate140$1,447
Ipratropium Bromide13$330
Ofloxacin14$249
Methylprednisolone27$185
Cephalexin34$132
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$119
Montelukast Sodium18$99
Mupirocin15$93
Amoxicillin13$15

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →